Corporate Actions Calendar

Corporate actions indicate company's financial performance and can signal about its future prospects. Have a sneak peak at all the Corporate actions scheduled in the near future.

MONTHLY

Corporate Actions Calender

September 2015

Tue Wed Thur Fri Sat Sun Mon
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

2 Corporate Actions for Feb 05 2023

03 Feb 23 | 3:59 PM

1 - 2 of 2

  • P & G Health Ltd
    P & G Health Ltd

    Event Type: Result

    • Latest Trading Price

      4,096.95

      16.750.41%

    • Details

      Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday February 8 2023 inter alia to consider and approve the unaudited financial results for the quarter ended December 312022 and the declaration of interim dividend for the Financial Year 2022-23 if any.Kindly take the same on record. Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2023 ,inter alia, to consider and approve With reference to the announcement dated January 09,2023 and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is now rescheduled to be held on Sunday, February 5, 2023, inter alia, to consider and approve the unaudited financial results for the quarter ended December 31,2022. We would like to further inform you that the Board at the said meeting, would also consider the declaration of interim dividend for the Financial Year 2022-23. The record date for payment of the Interim dividend, if declared at the Board meeting, will be Monday, February 13, 2023.With reference to the announcement dated January 09,2023 and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is now rescheduled to be held on Sunday, February 5, 2023, inter alia, to consider and approve the unaudited financial results for the quarter ended December 31,2022. We would like to further inform you that the Board at the said meeting, would also consider the declaration of interim dividend for the Financial Year 2022-23. The record date for payment of the Interim dividend, if declared at the Board meeting, will be Monday, February 13, 2023.(As per BSE Announcement Dated on 16/01/2023)

      Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday February 8 2023 inter alia to consider and approve the unaudited financial results for the quarter ended December 312022 and the declaration of interim dividend for the Financial Year 2022-23 if any.Kindly take the same on record. Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2023 ,inter alia, to consider and approve With reference to the announcement dated January 09,2023 and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is now rescheduled to be held on Sunday, February 5, 2023, inter alia, to consider and approve the unaudited financial results for the quarter ended December 31,2022. We would like to further inform you that the Board at the said meeting, would also consider the declaration of interim dividend for the Financial Year 2022-23. The record date for payment of the Interim dividend, if declared at the Board meeting, will be Monday, February 13, 2023.With reference to the announcement dated January 09,2023 and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is now rescheduled to be held on Sunday, February 5, 2023, inter alia, to consider and approve the unaudited financial results for the quarter ended December 31,2022. We would like to further inform you that the Board at the said meeting, would also consider the declaration of interim dividend for the Financial Year 2022-23. The record date for payment of the Interim dividend, if declared at the Board meeting, will be Monday, February 13, 2023.(As per BSE Announcement Dated on 16/01/2023)
  • J K Cements
    J K Cements

    Event Type: Result

    • Latest Trading Price

      2,630.90

      -49.20-1.84%

    • Details

      J.K.CEMENT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the Listing Regulations a meeting of the Board of Directors of the Company is scheduled to be held at Nimbahera Rajasthan on 5th February 2023 interalia to consider approve and take on record (1) Un-audited Consolidated and Standalone Financial Result Q.E.31.12.2022 (2) consider and approve the proposal of Issuance of Non Convertible Debentures on private placement basis

      J.K.CEMENT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the Listing Regulations a meeting of the Board of Directors of the Company is scheduled to be held at Nimbahera Rajasthan on 5th February 2023 interalia to consider approve and take on record (1) Un-audited Consolidated and Standalone Financial Result Q.E.31.12.2022 (2) consider and approve the proposal of Issuance of Non Convertible Debentures on private placement basis